We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

22 hedge funds and large institutions have $3.63M invested in Tonix Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

22% more capital invested

Capital invested by funds: $2.99M → $3.63M (+$642K)

16% more funds holding

Funds holding: 19 → 22 (+3)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

Holders
22
Holders Change
+3
Holders Change %
+15.79%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
4
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
+$1.94M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$388K
3
RJA
Raymond James & Associates
Florida
+$69K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$51.8K
5
TSS
Two Sigma Securities
New York
+$25.9K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$311K
2
Renaissance Technologies
Renaissance Technologies
New York
-$293K
3
Millennium Management
Millennium Management
New York
-$164K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$123K
5
Two Sigma Investments
Two Sigma Investments
New York
-$77.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
26
Osaic Holdings
Arizona
$1K – – –
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
$392 – – –
AF
28
Allworth Financial
California
$390 – – –
Federated Hermes
29
Federated Hermes
Pennsylvania
$354 – – –
NL
30
NVWM LLC
Pennsylvania
$339 – – –
Wells Fargo
31
Wells Fargo
California
$153 – – –
GRP
32
Global Retirement Partners
California
$152 – – –
FWM
33
Focused Wealth Management
New York
$87 – – –
FDCDDQ
34
Federation des caisses Desjardins du Quebec
Quebec, Canada
$62 – – –
BHWM
35
Beaird Harris Wealth Management
Texas
$31 – – –
GI
36
Gradient Investments
Minnesota
$25 – – –
NSIM
37
North Star Investment Management
Illinois
$15 – – –
GWSA
38
Global Wealth Strategies & Associates
Colorado
$7 – – –
TLCM
39
Twin Lakes Capital Management
California
$7 – – –
Hudson Bay Capital Management
40
Hudson Bay Capital Management
Connecticut
– -$123K -12 Closed
Goldman Sachs
41
Goldman Sachs
New York
– -$18K -2 Closed
Citadel Advisors
42
Citadel Advisors
Florida
– -$14K -1 Closed
Man Group
43
Man Group
United Kingdom
– -$14K -1 Closed
Qube Research & Technologies (QRT)
44
Qube Research & Technologies (QRT)
United Kingdom
– -$8K -1 Closed
TRCT
45
Tower Research Capital (TRC)
New York
– -$6K -1 Closed
1
2

TNXP Hedge Fund Activity: Q4 2022 in Review

22 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q4 2022, worth a combined $3.63M — up 22% from $2.99M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new TNXP positions and 7 closed out — a net gain of 3 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was Tang Capital Management, opening a new position worth an estimated $1.94M. The largest seller was Morgan Stanley, cutting an estimated $311K.

  • 22 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q4 2022, up from 19 in Q3 2022.
  • Funds reported $3.63M of Tonix Pharmaceuticals stock for Q4 2022, up 22% quarter-over-quarter.
  • 10 funds opened new Tonix Pharmaceuticals positions in Q4 2022 and 7 closed out, a net change of +3 holders.
  • The largest Tonix Pharmaceuticals buyer in Q4 2022 was Tang Capital Management, an estimated $1.94M added.
  • The largest Tonix Pharmaceuticals seller in Q4 2022 was Morgan Stanley, an estimated $311K sold.

Based on aggregated 13F filings for Q4 2022.